Alto Neuroscience (ANRO) Retained Earnings (2023 - 2026)

Alto Neuroscience has disclosed Retained Earnings across 4 years of filings, most recently posting -$227.9 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$227.9 million, down 48.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$227.9 million (down 48.37% YoY), and the FY2025 annual result was -$201.6 million, down 199537.62% from the prior year.
• Retained Earnings came in at -$227.9 million for Q1 2026 at Alto Neuroscience, down from -$201.6 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$79000.0 in Q4 2023 to a low of -$227.9 million in Q1 2026.
• The 4-year median for Retained Earnings is -$130.0 million (2024), against an average of -$104.7 million.
• Across the five-year window, Retained Earnings slipped 27.85% in 2024 and sank 199537.62% in 2025, its largest moves.
• Alto Neuroscience's Retained Earnings stood at -$79000.0 in 2023, then declined by 27.85% to -$101000.0 in 2024, then tumbled by 199537.62% to -$201.6 million in 2025, then fell by 13.03% to -$227.9 million in 2026.
• The last three Retained Earnings figures came in at -$227.9 million (Q1 2026), -$201.6 million (Q4 2025), and -$185.5 million (Q3 2025), per Business Quant data.